Humacyte HUMA
NASDAQ HUMA
$0.44 +0.03 (+7.32%)
At close: Oct 23, 2026 · 4:00 PM EDT

Humacyte (HUMA) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Humacyte (HUMA) recorded Return on Capital Employed [ROCE] of -101.63% in Q2 2026, down 15.78 percentage points from -85.85% a year earlier but up 15.45 percentage points from the prior quarter.

Analysis

Humacyte (HUMA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Humacyte reported Return on Capital Employed [ROCE] of -99.44%, up 1.72 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a four-year change of -55.68 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -101.16% in FY2024 (-33.47 pp), -67.68% in FY2023 (-30.22 pp), -37.46% in FY2022 (+6.30 pp) and -43.76% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has ranged from -126.40% in Q4 2025 to -28.60% in Q4 2021 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for 15 consecutive quarters, with an average year-over-year change of -19.16 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 37.90 percentage points in Q2 2022, against a drop of 40.62 percentage points in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -117.08% (Q1 2026), -126.40% (Q4 2025) and -117.68% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.52%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 17.92%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.28%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 16.76%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 16.66%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.86%
10 Humacyte 122.23 Mn -76.21 Mn -825,000.00 -101.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -101.63%
Mar 31, 2026 -117.08%
Dec 31, 2025 -126.40%
Sep 30, 2025 -117.68%
Jun 30, 2025 -85.85%
Mar 31, 2025 -85.28%
Dec 31, 2024 -107.58%
Sep 30, 2024 -106.53%
Jun 30, 2024 -80.89%
Mar 31, 2024 -79.61%
Dec 31, 2023 -83.09%
Sep 30, 2023 -65.92%
Jun 30, 2023 -56.98%
Mar 31, 2023 -50.19%
Dec 31, 2022 -43.25%
Sep 30, 2022 -39.12%
Jun 30, 2022 -33.75%
Mar 31, 2022 -31.43%
Dec 31, 2021 -28.60%
Sep 30, 2021 -41.65%
API Access

Humacyte Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=HUMA&period=max&api_key=YOUR_API_KEY